Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Sarcoma 4Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Glioblastoma 2Endometrial Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Neurilemmoma 1Nerve Sheath Neoplasms 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Carcinoma 1Meningioma 1Male Urogenital Diseases 1Lung Neoplasms 1Locally Recurrent Rectal Cancer 1Head and Neck Neoplasms 1Female Urogenital Diseases 1

Interventions

Leucovorin 2Fluorouracil 2Cetuximab 2Bevacizumab 2spartalizumab 1sintilimab 1Radiotherapy 1Radiation Dose Hypofractionation 1Oxaliplatin 1Irinotecan 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Recurrent Rectal Cancer × Radiation Dose Hypofractionation × Clear all
NCT06928584 2025-04-15

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Fudan University

Phase 2 Recruiting
221 enrolled
Gastrointestinal

Locally Recurrent Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡